首页> 美国卫生研究院文献>British Medical Journal >Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke—Blood Pressure) randomised controlled trial
【2h】

Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke—Blood Pressure) randomised controlled trial

机译:有中风或短暂性脑缺血发作病史的患者不同的收缩压目标:PAST-BP(中风后预防—血压)随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective To assess whether using intensive blood pressure targets leads to lower blood pressure in a community population of people with prevalent cerebrovascular disease.>Design Open label randomised controlled trial.>Setting 99 general practices in England, with participants recruited in 2009-11.>Participants People with a history of stroke or transient ischaemic attack whose systolic blood pressure was 125 mm Hg or above.>Interventions Intensive systolic blood pressure target (<130 mm Hg or 10 mm Hg reduction from baseline if this was <140 mm Hg) or standard target (<140 mm Hg). Apart from the different target, patients in both arms were actively managed in the same way with regular reviews by the primary care team.>Main outcome measure Change in systolic blood pressure between baseline and 12 months.>Results 529 patients (mean age 72) were enrolled, 266 to the intensive target arm and 263 to the standard target arm, of whom 379 were included in the primary analysis (182 (68%) intensive arm; 197 (75%) standard arm). 84 patients withdrew from the study during the follow-up period (52 intensive arm; 32 standard arm). Mean systolic blood pressure dropped by 16.1 mm Hg to 127.4 mm Hg in the intensive target arm and by 12.8 mm Hg to 129.4 mm Hg in the standard arm (difference between groups 2.9 (95% confidence interval 0.2 to 5.7) mm Hg; P=0.03).>Conclusions Aiming for target below 130 mm Hg rather than 140 mm Hg for systolic blood pressure in people with cerebrovascular disease in primary care led to a small additional reduction in blood pressure. Active management of systolic blood pressure in this population using a <140 mm Hg target led to a clinically important reduction in blood pressure.>Trial registration Current Controlled Trials ISRCTN29062286.
机译:>目的:评估在患有脑血管疾病的社区人群中使用密集的血压目标是否会降低血压。>设计开放标签随机对照试验。>设置在英格兰的99种常规做法,于2009-11年招募了参与者。>参与者具有中风或短暂性缺血发作病史且收缩压在125 mm Hg或以上的人。>干预措施。严格的收缩压目标(如果<140 mm Hg,则从基线降低<130 mm Hg或从基线降低10 mm Hg)或标准目标(<140 mm Hg)。除了不同的目标外,基层医疗团队定期对两臂患者进行积极管理,并定期进行检查。>主要结局指标:基线和12个月之间收缩压的变化。>结果招募了529例患者(平均年龄72岁),其中266例为强化靶组,263例为标准靶组,其中379例纳入了初次分析(182(68%)强化组); 197例(75 %)标准手臂)。在随访期间有84名患者退出研究(52支强力臂; 32支标准臂)。强化目标臂的平均收缩压下降16.1 mm Hg至127.4 mm Hg,标准臂的平均收缩压下降12.8 mm Hg至129.4 mm Hg(2.9组之间的差异(95%置信区间0.2至5.7)mm Hg; P = 0.03)。>结论针对初级保健中脑血管疾病患者的收缩压低于130 mm Hg而不是140 mm Hg的目标导致血压进一步降低。使用<140 mm Hg靶标主动管理该人群的收缩压可导致临床上重要的血压降低。>试验注册。电流控制试验为ISRCTN29062286。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号